Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 3 (2006), Issue 5 (May)

1. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
   Clin Pharmacol Ther, 79(5): 489-99. [Abstract] [Full-text]
2. Overexpression of kidney neutral endopeptidase (EC 3.4.24.11) and renal function in experimental cirrhosis.
   Am J Physiol Renal Physiol, 290(6): F1337-43. [Abstract] [Full-text]
3. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
   Am J Physiol Gastrointest Liver Physiol, 290(6): G1318-28. [Abstract] [Full-text]
4. Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.
   Am J Physiol Gastrointest Liver Physiol, 290(6): G1124-30. [Abstract] [Full-text]
5. Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: results from the HALT-C trial.
   Am J Gastroenterol, 101(5): 983-92. [Abstract] [Full-text]

© 2004-2008 Liver Cirrhosis Research Today. All Rights Reserved.